Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: An open-label randomised substudy of the ANRS IPERGAY trial
The Lancet Infectious Diseases Mar 02, 2018
Molina JM, et al. - This study was performed to assess if post-exposure prophylaxis (PEP) with doxycycline could reduce the incidence of sexually transmitted infections (STIs) in men who have sex with men. Outcomes showed a reduction in the occurrence of a first episode of bacterial STI with doxycycline PEP use in high-risk men who have sex with men.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
